NeuBase Therapeutics, Inc.

NBSE · NASDAQ
Analyze with AI
9/30/2023
6/30/2023
3/31/2023
12/31/2022
Assets
Cash & Equivalents$12,570$14,747$13,845$17,386
Short-Term Investments$0$0$0$0
Receivables$0$0$0$150
Inventory$0$0$109$255
Other Curr. Assets$93$399$259$175
Total Curr. Assets$13,352$15,518$14,214$17,966
Property Plant & Equip (Net)$5,144$6,691$6,995$7,344
Goodwill$0$0$0$0
Intangibles$0$0$0$0
Long-Term Investments$0$0$0$0
Tax Assets$0$0$0$0
Other NC Assets$125$125$251$273
Total NC Assets$5,269$6,816$7,245$7,617
Other Assets$0$0$0$0
Total Assets$18,621$22,334$21,459$25,583
Liabilities
Payables$259$322$590$370
Short-Term Debt$501$510$529$548
Tax Payable$30$30$110$217
Deferred Revenue$462$1,052$0$0
Other Curr. Liab.$3,429$4,239$801$1,228
Total Curr. Liab.$4,650$6,123$1,920$2,145
LT Debt$4,834$4,964$5,091$5,214
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.-$0-$0$0$0
Total NC Liab.$4,834$4,964$5,091$5,214
Other Liabilities$0$0$0$0
Cap. Leases$5,335$5,474$5,620$5,762
Total Liabilities$9,485$11,087$7,011$7,359
Equity
Pref Stock$0$0$0$0
Common Stock$0$0$3$3
Retained Earnings-$116,474-$114,653-$111,207-$107,113
AOCI$0$0$0$0
Other Equity$125,611$125,899$125,651$125,334
Total Equity$9,137$11,246$14,448$18,224
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$18,621$22,334$21,459$25,583
Net Debt-$7,235-$9,273-$8,225-$11,624